Head of Investor Relations
Vertex Pharmaceuticals Inc (VRTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Vertex Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get VRTX alertsMichael Partridge is recorded as Head of Investor Relations at Vertex Pharmaceuticals Inc (VRTX). Michael Partridge has spoken on 5 earnings calls across 1 company, most recently for Vertex Pharmaceuticals Inc on April 29, 2021. Vertex Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vertex Pharmaceuticals Inc includes Dr. Reshma Kewalramani (CEO), Reshma Kewalramani (CEO and Board Member), Dr. Jeffrey M. Leiden (Chairman) and 7 others.
“Making prepared remarks on the call tonight, we have Dr. Reshma Kewalramani, Vertex’s CEO and President; Stuart Arbuckle, Chief Commercial and Operations Officer; and Charlie Wagner, Chief Financial Officer.”
“Making prepared remarks on the call tonight, we have Dr. Reshma Kewalramani, Vertex's CEO and President; Stuart Arbuckle, Chief Commercial Officer; and Charlie Wagner, Chief Financial Officer.”
“Making prepared remarks on the call tonight, we have Dr. Reshma Kewalramani, Vertex's CEO and President; Stuart Arbuckle, Chief Commercial Officer; and Charlie Wagner, Chief Financial Officer; Dr. David Altshuler, Chief Scientific Officer, will join the Q&A portion of the call following the prepared remarks.”
“Making prepared remarks on the call tonight, we have Dr. Reshma Kewalramani, Vertex's CEO and President, Stuart Arbuckle, Chief Commercial Officer and Charlie Wagner, Chief Financial Officer.”
“Making prepared remarks on the call tonight, we have Dr. Reshma Kewalramani, Vertex’s CEO and President; Stuart Arbuckle, Chief Commercial Officer; and Charlie Wagner, Chief Financial Officer.”
Biotechnology · Healthcare
Head of Investor Relations
